Reckitt Benckiser shares rose 0.17% to 5,325p at 14:42 GMT after buying back 140,000 shares as part of a new £540 million tranche led by Deutsche Bank. The buyback follows a 6%
GE Vernova Inc. rose 0.1% to $831.30 in late Monday trading as U.S. markets fell on Trump’s surprise 15% tariff announcement. The company reported $150 billion in backlog and a quarterly dividend of $0.50 per share. Dominion Energy raised its five-year capital plan to $64.7 billion. Nvidia reports Q4 results on Feb. 25.
BAE Systems shares rose 0.3% to 2,306 pence in late London trading Friday, extending Thursday’s 3.14% jump to a record high. The FTSE 100 fell 0.3% as defense stocks outperformed amid oil above $100 a barrel and shipping disruptions in the Persian Gulf. BAE completed a key satellite program milestone and announced buybacks. Leonardo shares hit a record after unveiling a new tech-focused strategy.
Reckitt Benckiser shares rose 0.17% to 5,325p at 14:42 GMT after buying back 140,000 shares as part of a new £540 million tranche led by Deutsche Bank. The buyback follows a 6% drop after full-year results, with investors wary of 2026 margin and EPS outlooks. CEO Kris Licht highlighted strong emerging market sales, while management flagged lingering costs from recent divestments.
Rolls-Royce shares fell 1.83% to about 1,260 pence by 13:03 GMT Friday despite Moody’s raising its credit rating to A3. The company forecasts 2026 operating profit of £4.0–4.2 billion and free cash flow of £3.6–3.8 billion, with a share buyback of £7–9 billion planned through 2028. Rolls-Royce flagged a £150–200 million cash flow hit next year from supply chain issues.
Reckitt Benckiser shares fell 0.69% to 5,351 pence Thursday, extending a 6% weekly drop. The company bought 138,000 shares for treasury on March 11 as part of a £1 billion buyback. Investors remain cautious after last week's earnings shock and lack of margin guidance for 2026. FTSE 100 also slipped amid Middle East tensions and inflation concerns.
Clough CEO Peter Bennett has died at age 59, the company said Thursday, declining to disclose the cause. Clough has not named an interim chief and said details would be announced “in due course.” Bennett led the firm through its 2022 insolvency and Webuild’s 2023 takeover. The company employs over 3,000 people and manages projects worth nearly A$18 billion.
Reckitt Benckiser launched the third phase of its £1 billion share buyback, repurchasing £540 million in shares days after annual results. Shares fell 10.6% for the week ending March 10, underperforming the FTSE 350. The company reported 5.2% growth in 2025 comparable sales but warned of market pressures and slow growth in some divisions. Reckitt returned about £0.9 billion to shareholders in 2025.
PayPal shares rose 6.7% to $47.02 after Bloomberg reported Stripe is considering a bid for part or all of the company. Talks remain in early stages and both firms declined comment. PayPal named Enrique Lores as CEO effective March 1. The company also disclosed a data breach involving its Working Capital loan application.
UnitedHealth Group shares fell 2.6% to $273.95 in after-hours trading Tuesday, deepening a two-day drop of about 5.5%. The decline comes as investors brace for potential changes to Medicare Advantage payments, with a key public comment deadline set for Feb. 25. Other major health insurers, including Humana and Elevance, also closed lower despite gains in broader indexes.
Western Digital shares fell 2.8% to $272.65 Tuesday after a late Monday SEC filing revealed a planned insider sale of 130 restricted shares by Chief Legal Officer Cynthia Lock Tregillis. The stock traded between $267.85 and $284.00 amid volatile tech markets and recent sector weakness.
Sandisk shares jumped 5.2% to $683.53 in early New York trading Monday, rebounding from $645.88 amid heavy volume. The move follows Western Digital’s plan to sell about 5.8 million Sandisk shares to cut debt. Investors await signals on AI infrastructure demand ahead of Sandisk executives’ appearance at a Bernstein forum Wednesday. Western Digital shares rose 0.8% at the open.
GE Vernova Inc. rose 0.1% to $831.30 in late Monday trading as U.S. markets fell on Trump’s surprise 15% tariff announcement. The company reported $150 billion in backlog and a quarterly dividend of $0.50 per share. Dominion Energy raised its five-year capital plan to $64.7 billion. Nvidia reports Q4 results on Feb. 25.
IREN Limited rose nearly 6% to $42.28 in Monday afternoon trading, outpacing other U.S.-listed crypto miners despite a slight bitcoin decline. The stock is set to join the MSCI USA index after markets close Feb. 27. Cantor Fitzgerald disclosed it sold its 3.47 million-share IREN stake and added put options by year-end. IREN posted a Q4 net loss of $155.4 million as it shifts from bitcoin mining to AI cloud services.
SELLAS Life Sciences rose 3.4% to $4.29 in premarket trading Monday after closing Friday at $4.15 on heavy volume. Traders are watching for the 80th event in the phase 3 REGAL trial for AML, with results expected by mid-March. Short interest stands at 41.33 million shares, or 24.4% of float. SELLAS reported $71.8 million in cash at year-end, plus $26.5 million from recent warrant exercises.
Barclays shares rose 1.1% to 478.9 pence in early London trading after the bank announced it bought back 4.21 million shares for cancellation on February 20. The buyback, executed via J.P. Morgan, brought the total repurchased since February 10 to 25.38 million shares. Lloyds and HSBC shares also gained. HSBC’s full-year results are due Wednesday.
Corning shares jumped 7.3% to $139.51 Friday after UBS raised its price target to $160 and reiterated a “buy” rating. The stock hit an intraday high of $140.27, fueled by optimism over rising data center investment. Investors await management appearances at conferences next week for updates on demand.
U.S. regulators approved a new first-line treatment for chronic lymphocytic leukemia combining AbbVie’s Venclexta and AstraZeneca’s Calquence, citing improved progression-free survival over standard therapy. AbbVie shares closed up 0.21% at $224.81 Friday. Barclays initiated coverage with an “overweight” rating and $275 target. Investors await further market reaction when trading resumes Monday.
UnitedHealth shares closed Friday at $290, up just 0.02%, after a volatile session. New federal data show Medicare Advantage enrollment growth is slowing, with about 35.5 million members in early February. Insurers including UnitedHealthcare and Aetna have cut benefits and exited some regions. CMS will close public comments on proposed 2027 payment changes on Feb. 25.
Cisco closed Friday at $79.20, up 0.8%, marking a third straight gain. Chief operating officer Thimaya K. Subaiya sold 10,233 shares for nearly $804,000 under a preset plan. Cisco now expects AI orders to top $5 billion, but forecasts non-GAAP gross margin for the quarter at 65.5% to 66.5%. Investors await Nvidia’s results next week for signals on AI infrastructure spending.
Oracle shares fell 5.4% Friday to $148.08, underperforming the broader market despite easing trade uncertainty after a U.S. Supreme Court ruling. The drop followed reports that OpenAI plans to spend $600 billion on computing by 2030 and is preparing for an IPO. Nvidia is nearing a $30 billion investment in OpenAI. Oracle’s stock remains closely tied to AI investment sentiment.
CrowdStrike shares fell 7.9% to $388.60 Friday after Anthropic launched its AI code security tool, triggering a broader drop in cybersecurity stocks. Traders cited concerns that new AI products could disrupt software subscription models. Investors now await CrowdStrike’s March 3 earnings for signals on demand and AI-driven competition.
Trump Media & Technology Group fell 4.3% Friday, closing at $10.11. Yorkville America Equities agreed to acquire the MAGA ETF, aiming to complete the deal in Q2. The MAGA fund would be rebranded as Truth Social America First ETF, pending approvals. Investors await Monday’s market open, watching if DJT stays above $10 and for updates on the planned Trump Media token.
Oracle shares fell 5.4% to $148.08 in after-hours trading Friday, underperforming the broader U.S. market. OpenAI plans to spend $600 billion on computing by 2030, with Nvidia reportedly ready to invest $30 billion. Investors await Oracle’s 2026 financing details and Nvidia’s earnings on February 25. Oracle launched new AI and healthcare products this week.
Nebius Group (NBIS) shares fell about 8% to $99.12 on Nasdaq Friday after earlier reaching $108.30, with trading volume above 12.8 million shares. The drop followed a two-day rally of over 10% amid analyst upgrades and heavy options activity. Investors focused on Nebius’s 2026 expansion plans and funding risks ahead of earnings. The company recently agreed to acquire Tavily for cash.
Oracle shares fell 2.7% to $152.25 by 10:51 a.m. EST, trailing broader market gains. Nvidia is nearing a $30 billion investment in OpenAI as part of a funding round that could top $100 billion, according to a source. The S&P 500 rose 0.44% and the Nasdaq gained 0.62% after the U.S. Supreme Court struck down Trump-era tariffs.
Alphabet Class C shares rose 2.1% to $309.87 in early Friday trading after Google launched a preview of Gemini 3.1 Pro for Vertex AI and Gemini Enterprise customers. Google and Sea announced plans to develop an AI shopping prototype for Shopee. U.S. GDP grew 1.4% in Q4, below forecasts, while inflation data came in higher than expected.